Anti-OAcGD2 antibody in combination with ceramide kinase inhibitor mediates potent antitumor cytotoxicity against breast cancer and diffuse intrinsic pontine glioma cells.
Saved in:
| Title: | Anti-OAcGD2 antibody in combination with ceramide kinase inhibitor mediates potent antitumor cytotoxicity against breast cancer and diffuse intrinsic pontine glioma cells. |
|---|---|
| Authors: | Kasprowicz A; Univ Lille, CNRS, UMR 8576 - UGSF - Unité de Glycosbiologie Structurale et Fonctionnelle, 59655, Villeneuve d'Ascq, France.; OGD2Pharma, Institut de Recherche en Santé IRS2 - Nantes Biotech, Boulevard Benoni Goullin, 44200, Nantes, France., Cavdarli S; Univ Lille, CNRS, UMR 8576 - UGSF - Unité de Glycosbiologie Structurale et Fonctionnelle, 59655, Villeneuve d'Ascq, France., Delannoy P; Univ Lille, CNRS, UMR 8576 - UGSF - Unité de Glycosbiologie Structurale et Fonctionnelle, 59655, Villeneuve d'Ascq, France., Le Guezennec X; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore, 138673, Republic of Singapore., Defebvre C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, 59000, Lille, France., Spriet C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, 59000, Lille, France., Jonckheere N; Univ Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000, Lille, France., Le Doussal JM; OGD2Pharma, Institut de Recherche en Santé IRS2 - Nantes Biotech, Boulevard Benoni Goullin, 44200, Nantes, France., Krzewinski-Recchi MA; Univ Lille, CNRS, UMR 8576 - UGSF - Unité de Glycosbiologie Structurale et Fonctionnelle, 59655, Villeneuve d'Ascq, France., Mitra S; Univ Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000, Lille, France., Meignan S; Univ Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000, Lille, France.; Tumorigenesis and Resistance to Treatment Unit, Centre Oscar Lambret, 59000, Lille, France., Groux-Degroote S; Univ Lille, CNRS, UMR 8576 - UGSF - Unité de Glycosbiologie Structurale et Fonctionnelle, 59655, Villeneuve d'Ascq, France. sophie.groux-degroote@univ-lille.fr. |
| Source: | Molecular and cellular biochemistry [Mol Cell Biochem] 2025 Apr; Vol. 480 (4), pp. 2555-2571. Date of Electronic Publication: 2024 Oct 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4919 (Electronic) Linking ISSN: 03008177 NLM ISO Abbreviation: Mol Cell Biochem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-4919 |
|---|---|
| DOI: | 10.1007/s11010-024-05127-5 |
